NEW YORK (GenomeWeb) – At the American Association of Clinical Chemistry meeting last week, UK-based engineering consultancy TTP launched a development service based around a pre-developed rapid molecular diagnostic platform and disposables.

The firm will now market the system to assay developers wishing to enter the point-of-care, or "point-of-clinic," market with their own tests on an OEM platform.

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.